Search results for "electroconvulsive therapy"

showing 10 items of 12 documents

Clinical Predictors of Response to Magnetic Seizure Therapy in Depression

2019

Objectives Magnetic seizure therapy (MST) is a novel convulsive brain stimulation method in clinical testing, which is used as an alternative for electroconvulsive therapy in patients with treatment-resistant depression (TRD). Preliminary studies have suggested that MST leads to fewer cognitive adverse effects than electroconvulsive therapy but has similar efficacy. However, the clinical predictors of response to MST have not been evaluated yet. This study aimed to investigate whether these predictors can be identified in patients with TRD. Methods Thirty-eight patients with TRD were included. As clinical predictors for treatment response, we used the diagnosis, sex, age, family history, an…

AdultMalemedicine.medical_specialtyAnhedoniaMagnetic Field Therapymedicine.medical_treatmentNeuroscience (miscellaneous)Depressive Disorder Treatment-Resistant03 medical and health sciences0302 clinical medicineElectroconvulsive therapyPredictive Value of TestsSeizuresInternal medicinemedicineHumansFamily historyAtypical depressionDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressionbusiness.industryHamilton Rating Scale for DepressionMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthTreatment OutcomeMagnetic seizure therapyBrain stimulationAnxietyFemalemedicine.symptombusinesshuman activities030217 neurology & neurosurgeryThe Journal of ECT
researchProduct

Effects of magnetic seizure therapy on anterograde and retrograde amnesia in treatment‐resistant depression

2019

Background Electroconvulsive therapy (ECT) is the gold standard for treatment-resistant depression (TRD). However, cognitive side effects, mainly anterograde and retrograde amnesia, frequently occur. Magnetic seizure therapy (MST) is tested using more focal seizure induction. However, the suggestion MST may be more beneficial than ECT because it causes fewer amnesia have not yet been comprehensively investigated using common neuropsychological testing specifically for ECT. We aimed to examine whether MST causes anterograde and retrograde amnesia. Methods Ten patients with TRD were treated with MST (8.9 [2] treatments) at 100% machine output, a frequency of 100 Hz and 657.4 (62) pulses per t…

AdultMalemedicine.medical_specialtyAnterograde amnesiamedicine.medical_treatmentAmnesiaNeuropsychological TestsAudiologybehavioral disciplines and activitiesDepressive Disorder Treatment-ResistantExecutive Function03 medical and health sciences0302 clinical medicineElectroconvulsive therapySeizuresmental disordersmedicineHumansElectroconvulsive Therapymedicine.diagnostic_testbusiness.industryRetrograde amnesiaNeuropsychological testMiddle AgedAmnesia Anterogrademedicine.disease030227 psychiatryPsychiatry and Mental healthClinical PsychologyMagnetic FieldsMagnetic seizure therapyBrain stimulationMental RecallAmnesia RetrogradeFemalemedicine.symptombusinesshuman activitiesTreatment-resistant depression030217 neurology & neurosurgeryDepression and Anxiety
researchProduct

Bipolar I and Bipolar II Disorder: Cognition and Emotion Processing

2006

Background. Cognitive impairment may be part of the endophenotype of bipolar disorder (BP), but little is known about patterns and severity of impairment in BP subgroups and their relation to depression. The same applies to deficits in emotion processing known to be present in BP.Method. To explore the relationship between depression and impairment in cognition and emotion processing and the differences between BP subgroups, we assessed 36 (25 BP I and 11 BP II) patients using a cognitive battery and a facial emotion recognition task.Results. BP patients were impaired compared to published norms on memory, naming and executive measures (Binomial Single Proportion tests, p<0·05). Cognitiv…

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentNeuropsychological TestsSeverity of Illness IndexBipolar II disorderElectroconvulsive therapymedicineHumansEffects of sleep deprivation on cognitive performanceBipolar disorderPsychiatryApplied PsychologySettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCognitive disorderCognitionmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthAffectEndophenotypeFemaleAdult Affect* Bipolar Disorder/diagnosis* Bipolar Disorder/epidemiology* Cognition Disorders/diagnosis Cognition Disorders/epidemiology Diagnostic and Statistical Manual of Mental Disorders Female Humans Male Neuropsychological Tests Severity of Illness Indexmedicine.symptomPsychologyCognition DisordersManiaClinical psychology
researchProduct

Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression.

1996

Summary Background Lesion and neuroimaging studies suggest that left prefrontal lobe dysfunction is pathophysiologically linked to depression. Rapid-rate transcranial magnetic stimulation (rTMS) to prefrontal structures has a lateralised effect on mood in normal volunteers, and several preliminary studies suggest a beneficial effect of rTMS on depression. However, adequately controlled studies have not been conducted. Methods We have studied the effects of focal rTMS on the depressive symptoms in 17 patients with medication-resistant depression of psychotic subtype. The study was designed as a multiple cross-over, randomised placebo-controlled trial. Sham rTMS and stimulation of different c…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentDrug ResistancePrefrontal CortexStimulationElectric Stimulation TherapyAudiologybehavioral disciplines and activitiesElectroconvulsive therapyNeuroimagingSurveys and Questionnairesmental disordersmedicineHumansPsychiatryPrefrontal cortexDepression (differential diagnoses)Depressive DisorderCross-Over Studiesbusiness.industryGeneral MedicineMiddle AgedTranscranial Magnetic StimulationTranscranial magnetic stimulationMoodMagnetic seizure therapyFemalebusinessLancet (London, England)
researchProduct

Degree of Postictal Suppression Depends on Seizure Induction Time in Magnetic Seizure Therapy and Electroconvulsive Therapy.

2017

OBJECTIVES Anesthesia is required for both magnetic seizure therapy (MST) and electroconvulsive therapy (ECT), although it has anticonvulsant properties. In this case, bispectral index (BIS) monitoring, a specific electroencephalogram-derived monitoring, can be used to find the optimal seizure induction time during anesthesia to elicit adequate seizures. A measurement of seizure adequacy in electroencephalogram is the postictal suppression. The purpose of this study was to investigate the influence of seizure induction time on the degree of postictal suppression by comparing BIS versus no-BIS monitoring in MST and ECT. METHODS Twenty patients with treatment-resistant depression were randoml…

AdultMalemedicine.medical_treatmentNeuroscience (miscellaneous)law.invention03 medical and health sciencesDepressive Disorder Treatment-Resistant0302 clinical medicineElectroconvulsive therapyConsciousness MonitorsElectromagnetic FieldsRandomized controlled triallawPredictive Value of TestsSeizuresmedicineHumansAnesthesiaProspective StudiesElectroconvulsive TherapyAgedPsychiatric Status Rating ScalesCross-Over Studiesbusiness.industryElectroencephalographyMiddle AgedCrossover study030227 psychiatryPsychiatry and Mental healthAnticonvulsantTreatment OutcomeMagnetic seizure therapyBispectral indexAnesthesiaBrain stimulationFemaleAnalysis of variancebusinesshuman activities030217 neurology & neurosurgeryThe journal of ECT
researchProduct

Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression

2016

Background: Electroconvulsive therapy (ECT) is a highly effective brain stimulation treatment for severe depression. Identifying neurochemical changes linked with ECT may point to biomarkers and predictors of successful treatment response. Methods: We used proton magnetic resonance spectroscopy (1H-MRS) to measure longitudinal changes in glutamate/glutamine (Glx), creatine (Cre), choline (Cho) and N-acetylaspartate (NAA) in the dorsal (dACC) and subgenual anterior cingulate cortex (sgACC) and bilateral hippocampus in patients receiving ECT scanned at baseline, after the second ECT session and after the ECT treatment series. Patients were compared with demographically similar controls at bas…

MaleBipolar Disordermedicine.medical_treatmentProton Magnetic Resonance SpectroscopyHippocampusHippocampuschemistry.chemical_compound0302 clinical medicineElectroconvulsive therapyMedicineCholinePharmacology (medical)Longitudinal StudiesElectroconvulsive TherapyDepression (differential diagnoses)PsychiatryDepressionPsychiatry and Mental healthmedicine.anatomical_structureMental HealthTreatment OutcomeCardiologyRegression AnalysisCognitive SciencesFemaleClinical psychologyResearch PaperAdultmedicine.medical_specialtyClinical SciencesCreatinebehavioral disciplines and activitiesGyrus Cinguli03 medical and health sciencesNeurochemicalClinical ResearchInternal medicinemental disordersHumansBiological PsychiatryAnterior cingulate cortexPsychiatric Status Rating ScalesDepressive DisorderDepressive Disorder Majorbusiness.industryNeurosciencesMajor030227 psychiatryBrain DisordersCross-Sectional Studiesnervous systemchemistryBrain stimulationbusiness030217 neurology & neurosurgeryBiomarkersFollow-Up Studies
researchProduct

Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study

2018

<b><i>Background:</i></b> No candidate biomarkers based on cerebrospinal fluid (CSF) have been identified as prognostic factors in patients with major depression treated with electroconvulsive therapy (ECT), yet. <b><i>Method:</i></b> Following different underlying hypotheses, we analysed baseline CSF levels of markers of neurodegeneration (tau proteins, β-amyloids and neurogranin), elements of the innate immune system (interleukin [IL]-6, neopterin, soluble CD14, soluble CD163, migration inhibitory factor and monocyte chemotactic protein 1), endocannabinoids, sphingolipids and Klotho before ECT in patients with depression (<i>n</i&gt…

MaleOncologymedicine.medical_treatmentchemistry.chemical_compound0302 clinical medicineCerebrospinal fluidElectroconvulsive therapyNeurogranincerebrospinal fluid [Sphingolipids]Electroconvulsive TherapyKlothoGlucuronidaseAged 80 and overtherapy [Depressive Disorder Major]NeopterinInterleukinMiddle AgedPsychiatry and Mental healthTreatment OutcomeNeuropsychology and Physiological Psychologycerebrospinal fluid [Biomarkers]cerebrospinal fluid [Glucuronidase]Biomarker (medicine)AntidepressantFemaleAdultmedicine.medical_specialtyklotho proteinYoung Adult03 medical and health sciencesInternal medicinemental disordersmedicineHumansddc:610Klotho ProteinsBiological Psychiatrycerebrospinal fluid [Nerve Degeneration]AgedDepressive Disorder MajorSphingolipidsbusiness.industrycerebrospinal fluid [Depressive Disorder Major]Immunity Innate030227 psychiatrychemistryNerve Degenerationcerebrospinal fluid [Endocannabinoids]businessBiomarkers030217 neurology & neurosurgeryEndocannabinoidsNeuropsychobiology
researchProduct

Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter?

2019

Gender differences play a pivotal role in the pathophysiology and treatment of major depressive disorder. This is strongly supported by a mean 2:1 female-male ratio of depression consistently observed throughout studies in developed nations. Considering the urgent need to tailor individualized treatment strategies to fight depression more efficiently, a more precise understanding of gender-specific aspects in the pathophysiology and treatment of depressive disorders is fundamental. However, current treatment guidelines almost entirely neglect gender as a potentially relevant factor. Similarly, the vast majority of animal experiments analysing antidepressant treatment in rodent models exclus…

MalePsychotherapistsex differencemedia_common.quotation_subjectmedicine.medical_treatmentReviewelectroconvulsive therapyCatalysisNeglectlcsh:ChemistryInorganic Chemistryendocrinology03 medical and health sciences0302 clinical medicineElectroconvulsive therapygendermedicineAnimalsHumansPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopyDepression (differential diagnoses)media_commonDepressive Disorder Majorantidepressantbusiness.industryOrganic ChemistryGeneral MedicineRapid-acting antidepressantrapid-actingmedicine.diseaseAntidepressive Agents030227 psychiatryComputer Science ApplicationsReview articleTreatment Outcomelcsh:Biology (General)lcsh:QD1-999(2R6R)-HydroxynorketaminedepressionTreatment strategyAntidepressantMajor depressive disorderFemaleKetaminebusiness030217 neurology & neurosurgery
researchProduct

Psychological and medico-legal perspectives on electroconvulsive therapy and patient-centered care: A short review of cross-cutting issues

2020

Electroconvulsive therapy is a treatment that, since its first administration, has been a major topic for debate within the scientific world. In recent years, the debate has become increasingly focused on the short- and/or long-term efficacy of electroconvulsive therapy, its appropriateness in clinical settings, its mechanism of action, the impact evaluation of transient and/or persistent adverse effects, and the drafting of international guidelines,etc.From the authors’ point of view, these themes are inevitably crossed by three other fundamental issues of significant psychological, relational, ethical, and medico-legal impact. Still, they are less studied than purely biomedical issues in …

Medico legal03 medical and health sciences0302 clinical medicinePsychotherapistElectroconvulsive therapymedicine.medical_treatmentElectroconvulsive therapy Medico-legal perspective Patient-centered care model Patient’s perspective Psychological perspective Therapist-patient relationshipmedicinePatient-centered carePsychology030217 neurology & neurosurgeryGeneral Psychology030227 psychiatry
researchProduct

Setting up an electroconvulsive therapy (ECT) Department in the Psychiatric Hospital “Dr. GH. Preda” of Sibiu

2019

Abstract Electroconvulsive therapy has a long history, with periods of approval and of contradiction. The electroconvulsive therapy department in our hospital has a long tradition: it was initiated in 1940 and used for a period of five decades, after which it was abandoned due to several reasons. Starting with the year 2019, it was desired to create a new ECT department that corresponds to the new modern requirements of ECT’s application (under anesthesia). This department was built according to the Portuguese model of the ECT department with the main purpose to increase the accessibility of psychiatric patients to this type of treatment, to decrease the number of hospitalization days for t…

medicine.medical_specialtyElectroconvulsive therapybusiness.industrymedicine.medical_treatmentEmergency medicineMedicinePsychiatric hospitalGeneral MedicinebusinesshumanitiesActa Medica Transilvanica
researchProduct